Article Details

Denali Therapeutics Announces Positive Interim Data from Phase 1/2 Study with ETV:IDS (DNL310 ...

Retrieved on: 2021-07-25 15:00:00

Tags for this article:

Click the tags to see associated articles and topics

Denali Therapeutics Announces Positive Interim Data from Phase 1/2 Study with ETV:IDS (DNL310 .... View article details on hiswai:

Excerpt

Denali Management will host a webinar today for analysts and investors beginning at approximately 11:30 a.m. Eastern Time. “The longer-term safety ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up